Slider

Indiana-based BioTech Collaborates with IU School of Medicine to Help Find a Cure for Alzheimer’s

Indianapolis, Indiana; March 2, 2020 – LGENIA, an Indiana-based biotechnology company which has to date focused on its partnership with the TB Drug Accelerator (sponsored by the Bill and Melinda Gates Foundation) announces today that it will collaborate with the Indiana University School of Medicine to discover new medicines for Alzheimer’s disease. The IU School of Medicine was recently awarded a $36 million grant from the National Institutes of Health to create an Alzheimer’s disease drug discovery center with the…
Read More